Key facts

Financial results (Full-year 2019)

Product Sales

Change at constant exchange rates

Core Earnings per Share

Change at constant exchange rates



SEC filings

SEC filings are those documents that we are required to file by virtue of our listing on the New York Stock Exchange. They contain mainly financial information.

These documents are also available for viewing on the SEC website at . The Company will send any holder of the Company’s securities, upon request, a hard copy of the Company’s complete audited financial statements free of charge. Requests may be made by writing to:

Company Secretary
AstraZeneca PLC
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA


Our pipeline

28365365体育在线Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.

166

projects in our pipeline

9

new molecular entities in our late-stage pipeline



Contact us

Investor enquiries

Main Contacts

Thomas Kudsk Larsen

28365365体育在线Henry Wheeler

Oncology

28365365体育在线Josie Afolabi

28365365体育在线BioPharmaceuticals (Respiratory & Immunology)

Craig Marks

28365365体育在线Finance, fixed income

Christer Gruvris

BioPharmaceuticals (CV, Metabolism)

28365365体育在线Tom Waldron

Other medicines

28365365体育在线Jennifer Kretzmann

Corporate access, retail investors

Nick Stone

BioPharmaceuticals (Renal), ESG

28365365体育在线US general enquiries


  • Annual reports

    28365365体育在线Our Annual Report provides a wide range of information about our global business.


  • Our Pipeline

    Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development